Van Putten T, Crumpton E, Yale C
Arch Gen Psychiatry. 1976 Dec;33(12):1443-6. doi: 10.1001/archpsyc.1976.01770120047004.
The extremes of drug compliance were studied in two groups of schizophrenics: 29 habitual drug-refusers who invariably discontinued medication only to be readmitted several months later, and 30 drug-complier patients who habitually came in for their refills or injections of antipsychotic medication. The drug-refusers experienced the resurgence of an ego-syntonic grandiose psychosis after they discontinued medication. The habitual compliers, in contrast, developed decompensations characterized by such dysphoric affects as depression, anxiety, virtual absence of grandiosity, and some awareness of illness. The refusal of these chronic schizophrenics to take their medication could not be attributed to social isolation, paranoid diagnosis, or secondary gain. A discriminant function analysis showed grandiosity to be the most powerful discriminating variable between the two groups. We interpret these findings to mean that some schizophrenics may prefer an ego-syntonic grandiose psychosis to a relative drug-induced normality.
29名习惯性拒药者,他们总是停药,几个月后又再次入院;以及30名药物依从性患者,他们习惯性地前来补充抗精神病药物或接受注射。拒药者停药后出现了一种自我和谐的夸大性精神病复发。相比之下,习惯性依从者出现了失代偿,其特征是出现诸如抑郁、焦虑等烦躁情绪,几乎没有夸大症状,并且对疾病有一定的认识。这些慢性精神分裂症患者拒绝服药不能归因于社会隔离、偏执诊断或继发获益。判别函数分析表明,夸大是两组之间最有力的判别变量。我们将这些发现解释为,一些精神分裂症患者可能更喜欢自我和谐的夸大性精神病,而不是相对药物诱导的正常状态。